ASGE Interventional IBD: Management of Complications | March 2022-Update of Medical Management of Ulcerative Colitis and Crohn's Disease

Video Transcription

Video Summary

In this video, Dr. David Rubin provides an update on the medical management of ulcerative colitis (UC) and Crohn's disease. He emphasizes the importance of clarifying the diagnosis of inflammatory bowel disease (IBD) and includes elements of prognosis and assessment of extraintestinal manifestations in the diagnosis process. Dr. Rubin discusses the goals of IBD management, which include inducing remission, maintaining remission, and preventing complications and progression. He highlights the importance of treat-to-target strategies and disease monitoring, using both patient-reported outcomes and objective markers of inflammation. Dr. Rubin also discusses the expanding treatment options for UC and Crohn's, including biological therapies and synthetic targeted small molecules, and provides guidance on how to choose therapies based on individual patient characteristics. He concludes by discussing the potential of combination therapy and the importance of patient adherence to maintenance therapy. Overall, Dr. Rubin emphasizes the need for a proactive and personalized approach to IBD management.

Asset Subtitle

David T. Rubin, MD, FASGE

Keywords

IBD management

remission

treat-to-target strategies

biological therapies

individual patient characteristics

maintenance therapy